JP2005525390A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525390A5
JP2005525390A5 JP2003579828A JP2003579828A JP2005525390A5 JP 2005525390 A5 JP2005525390 A5 JP 2005525390A5 JP 2003579828 A JP2003579828 A JP 2003579828A JP 2003579828 A JP2003579828 A JP 2003579828A JP 2005525390 A5 JP2005525390 A5 JP 2005525390A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
amino group
protected amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003579828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525390A (ja
JP4490110B2 (ja
Filing date
Publication date
Priority claimed from GBGB0207449.0A external-priority patent/GB0207449D0/en
Application filed filed Critical
Publication of JP2005525390A publication Critical patent/JP2005525390A/ja
Publication of JP2005525390A5 publication Critical patent/JP2005525390A5/ja
Application granted granted Critical
Publication of JP4490110B2 publication Critical patent/JP4490110B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003579828A 2002-03-28 2003-03-27 炎症性症状の治療のためのccr3拮抗薬としての、n−{[(2s)−4−(3,4−ジフルオロベンジル)モルホリン−2−イル]メチル}−2−{3−[(メチルスルホニル)アミノ]フェニル}アセトアミド Expired - Lifetime JP4490110B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207449.0A GB0207449D0 (en) 2002-03-28 2002-03-28 Novel compounds
PCT/EP2003/003339 WO2003082291A1 (en) 2002-03-28 2003-03-27 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Publications (3)

Publication Number Publication Date
JP2005525390A JP2005525390A (ja) 2005-08-25
JP2005525390A5 true JP2005525390A5 (https=) 2006-05-18
JP4490110B2 JP4490110B2 (ja) 2010-06-23

Family

ID=9933998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003579828A Expired - Lifetime JP4490110B2 (ja) 2002-03-28 2003-03-27 炎症性症状の治療のためのccr3拮抗薬としての、n−{[(2s)−4−(3,4−ジフルオロベンジル)モルホリン−2−イル]メチル}−2−{3−[(メチルスルホニル)アミノ]フェニル}アセトアミド

Country Status (22)

Country Link
US (1) US20060058299A1 (https=)
EP (1) EP1487453B1 (https=)
JP (1) JP4490110B2 (https=)
KR (1) KR20040095347A (https=)
CN (1) CN1642553A (https=)
AR (1) AR039177A1 (https=)
AT (1) ATE454892T1 (https=)
AU (1) AU2003216905A1 (https=)
BR (1) BR0308719A (https=)
CA (1) CA2479910A1 (https=)
DE (1) DE60330952D1 (https=)
ES (1) ES2339436T3 (https=)
GB (1) GB0207449D0 (https=)
IL (1) IL163648A0 (https=)
IS (1) IS7415A (https=)
MX (1) MXPA04009458A (https=)
NO (1) NO20044098L (https=)
PL (1) PL372930A1 (https=)
RU (1) RU2004126145A (https=)
TW (1) TW200400823A (https=)
WO (1) WO2003082291A1 (https=)
ZA (1) ZA200406990B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275257A1 (en) 2002-09-26 2004-04-19 Bristol-Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
EP1919884A1 (en) * 2005-07-21 2008-05-14 AstraZeneca AB N-benzyl-morpholine derivatives as modulators of the chemokine receptor
AU2006293635A1 (en) * 2005-09-22 2007-03-29 Sanofi-Aventis Amino-alkyl-amide derivatives as CCR3 receptor liquids
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0800478A2 (en) * 2008-07-31 2010-03-01 Sanofi Aventis Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
RU2014126070A (ru) * 2011-12-01 2016-01-27 Глэксо Груп Лимитед Способы лечения и предотвращения глазных заболеваний

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS562929A (en) * 1979-06-21 1981-01-13 Sumitomo Chem Co Ltd Preparation of optically active cyclopentenolone
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
JPH01117882A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 複素環式カルボン酸アミド誘導体
JPH03291274A (ja) * 1990-04-09 1991-12-20 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
JPH04270272A (ja) * 1991-02-25 1992-09-25 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
TW223629B (https=) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US6031097A (en) * 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
AU2056800A (en) * 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
JP4717306B2 (ja) * 1999-09-14 2011-07-06 アベンティスユービー・セカンド・インコーポレイテッド D4拮抗剤として有用なチエノイソキサゾールフェノキシ非置換エチルおよびプロピル誘導体
IL155093A0 (en) * 2000-09-29 2003-10-31 Glaxo Group Ltd Morpholin-acetamide derivatives for the treatment on inflammatory diseases
IL155092A0 (en) * 2000-09-29 2003-10-31 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases

Similar Documents

Publication Publication Date Title
EP1862458A3 (en) Therapeutic agents useful for treating pain
JP2006182786A5 (https=)
JP2005053931A5 (https=)
JP2003532731A5 (https=)
JP2007505877A5 (https=)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2006507265A5 (https=)
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
JP2002539128A5 (https=)
JP2020507589A5 (https=)
WO2005056524A3 (en) Therapeutic agents useful for treating pain
JP2011505356A5 (https=)
JP2005511699A5 (https=)
JP2005536503A5 (https=)
JP2006503850A5 (https=)
JP2008534453A5 (https=)
JP2005511602A5 (https=)
JP2004502684A5 (https=)
JP2005525390A5 (https=)
JP2009532434A5 (https=)
JP2012511558A5 (https=)
JP2006510659A5 (https=)
JP2004522781A5 (https=)